Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel

International Journal of Pharmaceutics

Volumn 454, Issue 2, 2013, Pages 703-711

  De Oliveira, Rachel ^a,b   Zhao, Pengxiang ^c   Li, Na ^c   De Santa Maria, Luiz Claudio ^a   Vergnaud, Juliette ^b   Ruiz, Jaime ^c   Astruc, Didier ^c   Barratt, Gillian ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIV PARIS SUD   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Docetaxel; Folate; Gold nanoparticles; LnCaP cells; PEG; Prostate cancer

Indexed keywords

DOCETAXEL; FOLIC ACID; GOLD NANOPARTICLE; MACROGOL; MACROGOL 2000; MACROGOL 400; MITOCHONDRIAL ENZYME; PEG 550; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; COVALENT BOND; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ENZYME ACTIVITY; FREEZE DRYING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; MOLECULAR WEIGHT; NANOENCAPSULATION; OPSONIZATION; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSMISSION ELECTRON MICROSCOPY;

DOCETAXEL; FOLATE; GOLD NANOPARTICLES; LNCAP CELLS; PEG; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; FOLIC ACID; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; POLYETHYLENE GLYCOLS; TAXOIDS;

EID: 84884146186     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.031     Document Type: Article

References (48)

1. Boisselier, E., Astruc, D., 2009. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38, 1759-1782.
2. Botosoa, E.P., Maillasson, M., Mougin-Degraef, M., Remaud-Le Saec, P., Gestin, J.-F., Jacques, Y., Barbet, J., Faivre-Chauvet, A., 2011. Antibody-hapten recognition at the surface of functionalized liposomes studied by SPR: steric hindrance of pegylated phospholipids in stealth liposomes prepared for targeted radionuclide delivery. J. Drug Deliv. 2011, 368535, http://dx.doi.org/10.1155/2011/368535.
3. Braydich-Stolle, L., Hussain, S., Schlager, J.J., Hofmann, M.-C., 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 88, 412-419. (Pubitemid 41672149)
4. Brown, S.D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P.R., Venugopal, B., Flint, D.J., Plumb, J.A., Graham, D., Wheate, N.J., 2010. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 132, 4678-4684.
5. Brust, M., Walker, M., Bethell, D., Schiffrin, D.J., Whyman, R., 1994. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J. Chem. Soc. Chem. Commun. 0, 801-802.
6. Copland, J.A., Eghtedari, M., Popov, V.L., Kotov, N., Mamedova, N., Motamedi, M., Oraevsky, A.A., 2004. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol. Imaging Biol. 6, 341-349. (Pubitemid 39243067)
7. Daniel, M.-C., Astruc, D., 2003. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293-346.
8. Farokhzad, O.C., Cheng, J., Teply, B.A., Sherifi, I., Jon, S., Kantoff, P.W., Richie, J.P., Langer, R., 2006. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 6315-6320.
9. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., Parkin, D.M., 2010. Cancer Incidence and Mortality Worldwide, vol. 10. International Agency for Research on Cancer. IARC CancerBase (accessed on 02/10/2012).
10. Ferrero, J.-M., Chamorey, E., Oudard, S., Dides, S., Lesbats, G., Cavaglione, G., Nouyrigat, P., Foa, C., Kaphan, R., 2006. Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer. Cancer 107, 738-745. (Pubitemid 44232666)
11. França, Á., Pelaz, B., Moros, M., Sánchez-Espinel, C., Hernández, A., Fernández-López, C., Grazú, V., de la Fuente, J.M., Pastoriza-Santos, I., Liz-Marzán, L.M., González-Fernández, Á., 2010. Sterilization matters: consequences of different sterilization techniques on gold nanoparticles. Small 6, 89-95.
12. François, A., Laroche, A., Pinaud, N., Salmon, L., Ruiz, J., Robert, J., Astruc, D., 2011. Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer cells. ChemMedChem 6, 2003-2008.
13. Gao, Y., Chen, L., Gu, W., Xi, Y., Lin, L., Li, Y., 2008. Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model. Mol. Pharm. 5, 1044-1054.
14. Gaucher, G., Dufresne, M.-H., Sant, V.P., Kang, N., Maysinger, D., Leroux, J.-C., 2005. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Release 109, 169-188. (Pubitemid 41742123)
15. Ghosh, A., Heston, W.D.W., 2004. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J. Cell. Biochem. 91, 528-539.
16. Ghosh, P., Han, G., De, M., Kim, C.K., Rotello, V.M., 2008. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 60, 1307-1315.
17. Hayes, A.J., Markovic, B., 2002. Toxicity of australian essential oil backhousia citriodora (Lemon myrtle), Part 1. Antimicrobial activity and in vitro cytotoxicity. Food Chem. Toxicol. 40, 535-543. (Pubitemid 34219280)
18. Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., Reuter, V., Gerald, W.L., 2004. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen responsive genes and mechanisms of therapy resistance. Am. J. Pathol. 164, 217-227. (Pubitemid 38364606)
19. Hwang, C., 2012. Overcoming docetaxel resistance in prostate cancer: a perspective review. Ther. Adv. Med. Oncol. 4, 329-340.
20. Jain, P.K., Huang, W., El-Sayed, M.A., 2007. On the universal scaling behavior of the distance decay of dlasmon doupling in metal nanoparticle pairs: a plasmon ruler equation. Nano Lett. 7, 2080-2088. (Pubitemid 47197596)
21. Kim, D., Jeong, Y.Y., Jon, S., 2010. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4, 3689-3696.
22. Kraus, L., Samuel, S., Schmid, S., Dykes, D., Waud, W., Bissery, M., 2003. The mechanism of action of docetaxel (Taxotere®) in xenograft models is not limited to bcl-2 phosphorylation. Invest. New Drugs 21, 259-268. (Pubitemid 37486328)
23. Lal, S., Clare, S.E., Halas, N.J., 2008. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc. Chem. Res. 41, 1842-1851.
24. Lee, S.B., 2007. Focus on nanoparticles for cancer diagnosis and therapeutics. Nanomedicine 2, 647-648. (Pubitemid 350268243)
25. Llevot, A., Astruc, D., 2012. Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. Chem. Soc. Rev. 41, 242-257.
26. Lyer, A.K., Khaled, G., Fang, J., Maeda, H., 2006. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11, 812-818. (Pubitemid 44280021)
27. Malich, G., Markovic, B., Winder, C., 1997. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124, 179-192. (Pubitemid 28055528)
28. Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E., Fernandes, J.C., 2006. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27, 2060-2065. (Pubitemid 41759500)
29. Mei, L., Zhang, Y., Zheng, Y., Tian, G., Song, C., Yang, D., Chen, H., Sun, H., Tian, Y., Liu, K., Li, Z., Huang, L., 2009. A novel docetaxel-loaded poly (ε-Caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res. Lett. 4, 1530-1539.
30. Mezynski, J., Pezaro, C., Bianchini, D., Zivi, A., Sandhu, S., Thompson, E., Hunt, J., Sheridan, E., Baikady, B., Sarvadikar, A., Maier, G., Reid, A.H.M., Mulick Cassidy, A., Olmos, D., Attard, G., de Bono, J., 2012. Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance? Ann. Oncol. 23, 2943-2947.
31. Mout, R., Moyano, D.F., Rana, S., Rotello, V.M., 2012. Surface functionalization of nanoparticles for nanomedicine. Chem. Soc. Rev. 41, 2539-2544.
32. Murphy, C.J., Gole, A.M., Stone, J.W., Sisco, P.N., Alkilany, A.M., Goldsmith, E.C., Baxter, S.C., 2008. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721-1730.
33. Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., Niidome, Y., 2006. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Controlled Release 114, 343-347. (Pubitemid 44310822)
34. Oudard, S., Banu, E., Beuzeboc, P., Voog, E., Dourthe, L.M., Hardy-Bessard, A.C., Linassier, C., Scotté, F., Banu, A., Coscas, Y., Guinet, F., Poupon, M.-F., Andrieu, J.-M., 2005. Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer. J. Clin. Oncol. 23, 3343-3351.
35. Paciotti, G.F., Kingston, D.G.I., Tamarkin, L., 2006. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev. Res. 67, 47-54. (Pubitemid 43765048)
36. Pissuwan, D., Valenzuela, S.M., Cortie, M.B., 2006. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol. 24, 62-67. (Pubitemid 43151977)
37. Raschke, G., Kowarik, S., Franzl, T., Sönnichsen, C., Klar, T.A., Feldmann, J., Nichtl, A., Kürzinger, K., 2003. Biomolecular recognition based on single gold nanoparticle light scattering. Nano Lett. 3, 935-938. (Pubitemid 37161875)
38. Sánchez-Moreno, P., Boulaiz, H., Ortega-Vinuesa, J.L., Peula-García, J.M., Aránega, A., 2012. Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells. Int. J. Mol. Sci. 13, 4906-4919.
39. Ungaro, F., Conte, C., Ostacolo, L., Maglio, G., Barbieri, A., Arra, C., Misso, G., Abbruzzese, A., Caraglia, M., Quaglia, F., 2012. Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. Nanomedicine 8, 637-646.
40. Viviani, B., Bartesaghi, S., Corsini, E., Villa, P., Ghezzi, P., Garau, A., Galli, C.L., Marinovich, M., 2005. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J. Neurochem. 93, 412-421. (Pubitemid 40547498)
41. Wang, Z., Lévy, R., Fernig, D.G., Brust, M., 2005. The peptide route to multifunctional gold nanoparticles. Bioconjugate Chem. 16, 497-500. (Pubitemid 40696039)
42. Yoshimoto, K., Hoshino, Y., Ishii, T., Nagasaki, Y., 2008. Binding enhancement of antigen-functionalized PEGylated gold nanoparticles onto antibody-immobilized surface by increasing the functionalized antigen using [small alpha]-sulfanyl-[small omega]-amino-PEG. Chem. Commun. 0, 5369-5371.
43. Zeng, S., Yong, K.-T., Roy, I., Dinh, X.-Q., Yu, X., Luan, F., 2011. A review on functionalized gold nanoparticles for biosensing applications. Plasmonics 6, 491-506.
44. Zhang, C., Gao, S., Jiang, W., Lin, S., Du, F., Li, Z., Huang, W., 2010. Targeted minicircle DNA delivery using folate-poly(ethylene glycol)- polyethylenimine as non-viral carrier. Biomaterials 31, 6075-6086.
45. Zhao, P., Astruc, D., 2012. Docetaxel nanotechnology in anticancer therapy. ChemMedChem 7, 952-972.
46. Zhao, P., Grillaud, M., Salmon, L., Ruiz, J., Astruc, D., 2012. Click functionalization of gold nanoparticles using the very efficient catalyst copper(I) (hexabenzyl)tris(2-aminoethyl)-amine bromide. Adv. Synth. Catal. 354, 1001-1011.
47. Zhao, P., Li, N., Astruc, D., 2013. State of the art in gold nanoparticle synthesis. Coord. Chem. Rev. 257, 638-665.
48. Zheng, M., Li, Z., Huang, X., 2004. Ethylene glycol monolayer protected nanoparticles: synthesis, characterization, and interactions with biological molecules. Langmuir 20, 4226-4235.